ST Pharm provides development and cGMP manufacturing for small-molecule APIs, oligonucleotides, mRNA, and lipid nanoparticle formulations. Its production platforms support clinical and commercial programs, with integrated monomer-to-oligonucleotide manufacturing, mRNA 5′-capping and LNP capabilities, and facilities inspected by global regulatory authorities, including the FDA.
Locations:
- San Diego, CA, USA
- Delaware, USA
- Atlanta, GA, USA
- Barcelona, Spain
- Basel, Switzerland,
- Seoul, South Korea
- Sihwa, South Korea
- Banwol, South Korea